185 related articles for article (PubMed ID: 32669451)
1. Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis.
den Braanker H; Wervers K; Mus AMC; Bangoer PS; Davelaar N; Luime J; Tchetverikov I; Hazes JMW; Vis M; Lubberts E; Kok MR
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32669451
[TBL] [Abstract][Full Text] [Related]
2. The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.
De Marco G; Helliwell P; McGonagle D; Emery P; Coates LC; Hensor EMA; Marzo-Ortega H
BMC Musculoskelet Disord; 2017 Jul; 18(1):303. PubMed ID: 28720139
[TBL] [Abstract][Full Text] [Related]
3. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
Sheane BJ; Thavaneswaran A; Gladman DD; Chandran V
J Rheumatol; 2016 Sep; 43(9):1718-23. PubMed ID: 27422895
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
5. Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.
Behrens F; Koehm M; Schwaneck EC; Schmalzing M; Wittig BM; Gnann H; Greger G; Tony HP; Burkhardt H
Scand J Rheumatol; 2019 Sep; 48(5):375-382. PubMed ID: 31311386
[No Abstract] [Full Text] [Related]
6. Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials.
Combe B; Behrens F; McHugh N; Brock F; Kerkmann U; Kola B; Gallo G
J Rheumatol; 2016 Jun; 43(6):1063-7. PubMed ID: 27134249
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis.
Appani SK; Devarasetti PK; Irlapati RVP; Rajasekhar L
Rheumatology (Oxford); 2019 May; 58(5):869-873. PubMed ID: 30590763
[TBL] [Abstract][Full Text] [Related]
8. Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial.
de Jong HMY; van Mens LJJ; Nurmohamed MT; Kok MR; van Kuijk AWR; Baeten DLP; van de Sande MGH
Arthritis Res Ther; 2019 Sep; 21(1):208. PubMed ID: 31521192
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review.
Ruhoff JT; Horn HC; Ellingsen T
Dan Med J; 2019 Oct; 66(10):. PubMed ID: 31571573
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
Funk RS; Chan MA; Becker ML
Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
[TBL] [Abstract][Full Text] [Related]
11. Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.
Behrens F; Koehm M; Arndt U; Wittig BM; Greger G; Thaçi D; Scharbatke E; Tony HP; Burkhardt H
J Rheumatol; 2016 Mar; 43(3):632-9. PubMed ID: 26669916
[TBL] [Abstract][Full Text] [Related]
12. The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study.
Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Lexberg AS; Rødevand E; Kalstad S; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2014 Jan; 73(1):132-7. PubMed ID: 23291385
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.
Sakellariou GT; Sayegh FE; Anastasilakis AD; Kapetanos GA
Rheumatol Int; 2013 Nov; 33(11):2917-20. PubMed ID: 23124729
[TBL] [Abstract][Full Text] [Related]
14. Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.
Korotaeva TV; Loginova EY; Getiya TS; Nasonov EL
Ter Arkh; 2018 May; 90(5):22-29. PubMed ID: 30701886
[TBL] [Abstract][Full Text] [Related]
15. Longterm therapy of psoriatic arthritis: intramuscular gold or methotrexate?
Lacaille D; Stein HB; Raboud J; Klinkhoff AV
J Rheumatol; 2000 Aug; 27(8):1922-7. PubMed ID: 10955334
[TBL] [Abstract][Full Text] [Related]
16. Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate.
van Mens LJJ; de Jong HM; Fluri I; Nurmohamed MT; van de Sande MGH; Kok M; van Kuijk AWR; Baeten D
Ann Rheum Dis; 2019 May; 78(5):610-616. PubMed ID: 30808625
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study.
Coates LC; Helliwell PS
J Rheumatol; 2016 Feb; 43(2):356-61. PubMed ID: 26669913
[TBL] [Abstract][Full Text] [Related]
18. Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
Mease PJ; Gladman DD; Collier DH; Ritchlin CT; Helliwell PS; Liu L; Kricorian G; Chung JB
Arthritis Rheumatol; 2019 Jul; 71(7):1112-1124. PubMed ID: 30747501
[TBL] [Abstract][Full Text] [Related]
19. Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry.
Mease PJ; Lesperance T; Liu M; Collier DH; Mason M; Deveikis S; Accortt NA
J Rheumatol; 2017 Feb; 44(2):184-192. PubMed ID: 28089969
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]